The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy

Polycystic ovary syndrome is a highly frequent reproductive-endocrine disorder affecting up to 8–10% of women worldwide at reproductive age. Although its etiology is not fully understood, evidence suggests that insulin resistance, with or without compensatory hyperinsulinemia, and hyperandrogenism a...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinedi, Eduardo, Cardinali, Daniel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083563/
https://www.ncbi.nlm.nih.gov/pubmed/30147722
http://dx.doi.org/10.1155/2018/1349868

Ejemplares similares

Ejemplares similares